Showing 661-670 of 1043 results for "".
Neurologists' Experiences with EHRs: The Texas Perspective
https://practicalneurology.com/columns/practice-management/neurologists-experiences-with-ehrs-the-texas-perspective/30779/The Texas Neurological Society surveyed its membership about their experiences with EHRs. Results show generally moderate to low satisfaction.Editor's Message: Should Expensive Therapies Be Avoided?
https://practicalneurology.com/columns/practice-management/editors-message-should-expensive-therapies-be-avoided/30792/How Biomarkers are Changing Knowledge and Management of Alzheimer's Disease
https://practicalneurology.com/columns/practice-management/how-biomarkers-are-changing-knowledge-and-management-of-alzheimers-disease/30807/Researchers and clinicians weigh in on the progress and potential of AD biomarker research.New AD Guidelines Focus on Early Disease
https://practicalneurology.com/columns/practice-management/new-ad-guidelines-focus-on-early-disease/30808/Editor's Message
https://practicalneurology.com/columns/practice-management/editors-message/30856/Using Diaries, Calendars and Technology to Improve Headache Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/1109_01-php/30870/From optimizing the benefits of paper calendars to embracing new electronic technologies, neurologists can gather crucial data to improve patient care.- Leaving AEDs Behind: When to Withdraw Therapy in Seizure-free Patientshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1008_04-pdf/30980/Managing Antiepileptic Drug (AED) Therapy in Seizure-Free Patients: Key ConsiderationsAchieving complete seizure control is the primary objective in epilepsy management, significantly improving patient quality of life. In specific epilepsy syndromes, such as benign rolandic epilepsy (childhood epile
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0608Dementia-pdf/31012/Current Alzheimer’s disease (AD) research predominantly targets the reduction and elimination of beta-amyloid 42 and phosphorylated Tau proteins, aiming to develop disease-modifying treatments. These pathological markers are critical in the onset and progression of AD, and intervening in their pathw
- Six Burning Questions about Diabetic Neuropathyhttps://practicalneurology.com/columns/practice-management/six-burning-questions-about-diabetic-neuropathy/31023/Diabetic Neuropathies: Current Insights and Management StrategiesDiabetic neuropathies are the most prevalent forms of neuropathy globally, presenting significant challenges in clinical management and research. Despite advancements in understanding their clinical manifestations, critical aspects suc
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31040/In the March 2008 issue of *Practical Neurology*, Editor-in-Chief Jack Persico delves into the critical debate of experience versus expertise within the medical field. Drawing parallels from the political arena, specifically the 2008 Democratic primary race where candidates like Hillary Clinton emph